"Chesapeake Urology is the largest, fully-integrated urology practice in Maryland and the Mid-Atlantic region, providing a comprehensive array of urologic services to patients. Our staff of more than 800 professionals, including more than 80 urologists and fellowship-trained specialists, focus on what’s most important to patients – superior and personalized care, an innovative approach to the most advanced diagnostics, leading-edge treatments, and clinical trials, as well as positive outcomes. At Chesapeake Urology, we’re dedicated to providing the most personal care for life’s most personal issues."

During the past decade, Chesapeake Urology Research Associates conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 16 clinical trials were completed, i.e. on average, 69.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chesapeake Urology Research Associates" #1 sponsor was "Allergan" with 3 trials, followed by "Dendreon" with 2 trials sponsored, "Endo Pharmaceuticals" with 2 trials sponsored, "Exosome Diagnostics, Inc." with 2 trials sponsored and "NeoTract, Inc." with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chesapeake Urology Research Associates" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Endo Pharmaceuticals" with 1 trials as a collaborator, "Janssen Scientific Affairs, LLC" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Chesapeake Urology Research Associates" are "Prostate Cancer" (11 trials), "Bladder Cancer" (4 trials), "Cystitis, Interstitial" (3 trials), "Overactive Bladder" (3 trials) and "Benign Prostatic Hyperplasia" (2 trials). Many other conditions were trialed in "Chesapeake Urology Research Associates" in a lesser frequency.

Most popular intervention types in "Chesapeake Urology Research Associates" are "Drug" (19 trials), "Device" (9 trials), "Biological" (7 trials), "Procedure" (5 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "LiRIS Placebo" (2 trials), "LiRIS®" (2 trials), "Prednisone" (2 trials) and "TURBT" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chesapeake Urology Research Associates" are 23 trials for "Male" genders, 10 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Chesapeake Urology Research Associates". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Chesapeake Urology Research Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Chesapeake Urology Research Associates, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".

Chesapeake Urology Research Associates has several departments that took part in Clinical trials: "Chesapeake Urology Research Associates" - 25 trials, "Chesapeake Urology" - 8 trials